Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

YO26 - Exacerbation of radiation necrosis around the radiotherapy-pretreated brain metastases site after immune checkpoint inhibitors.

Date

23 Nov 2019

Session

Poster display session

Topics

Immunotherapy

Tumour Site

Presenters

Minako Nishio

Authors

M. Nishio1, T. Otsuka2, K. Asai3, Y. Okita3, S. Otozai4, T. Fujii4, H. Yoshizawa5, S. Nakatsuka5, T. Kumagai6, F. Imamura7

Author affiliations

  • 1 Department Of Medical Oncology, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 2 Department Of Medical Oncology/thoracic Oncology, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 3 Department Of Neurosurgery, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 4 Department Of Head And Neck Surgery, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 5 Department Of Diagnostic Pathology And Cytology, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 6 Department Of Thoracic Oncology, Osaka International Cancer Institute, 541-8567 - Osaka/JP
  • 7 Department Of Medical Oncology/thoracic Oncology, Osaka International Cancer Institute, Osaka/JP

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract YO26

Case summary

As the survival of patients with brain metastases is being prolonged, due to improved systemic therapy, opportunities to use immune checkpoint inhibitor (ICI)s after SRT (stereotactic radiotherapy) or IMRT (Intensity Modulated Radiation Therapy) in patient with brain metastases are increasing. Radiation necrosis is known as a late toxicity of SRT and IMRT. However, few studies have examined the association between ICIs and radiation necrosis. Here we report two cases in which radiation necrosis was exacerbated after ICIs.

Case1: A 30-year-old female diagnosed with nasopharyngeal carcinoma who had direct invasion to the skull base and metastases to the vertebrae. After the concurrent chemoradiation, she had a locoregional recurrence. MRI showed the ring-enhancing lesion around the IMRT-pretreated site of the right temporal lobe, which was considered to be radiation necrosis. One week after the initiation of nivolumab, the patient developed disorientation and a headache. Brain CT showed the exacerbation of radiation necrosis. Corticosteroid administration improved the symptoms. Nivolumab was not reinitiated.

Case2: A 60-year-old male diagnosed with non-small cell lung cancer with brain metastases. He underwent IMRT for the right temporal lobe after undergoing bilateral craniotomy for multiple brain metastases. Because the paralysis progressed, he was performed resection of the brain enhancing lesion. The histopathological examination of the resected brain lesion revealed the presence of diffuse necrosis and gliosis with absence of viable tumor, which was compatible with radiation necrosis. One week after the initiation of atezolizumab, the patient developed hemiparesis. Brain CT showed the exacerbation of radiation necrosis. The patient then started treatment with corticosteroid, and hemiparesis was partly improved. The administration of atezolizumab was discontinued.

Conclusion: We experienced two cases of exacerbation of radiation necrosis following the initiation of the ICIs. Further investigation for the safety of using ICIs in patients with radiation necrosis is warranted.

Clinical trial identification

Editorial acknowledgement

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.